Treatment of iodolactone 8a, having a cyclopentano[c]pyran skeleton and deriving from aucubin (1) (Scheme 1), with sodium trimethylsilanolate permitted a straightforward rearrangement to bicyclo[3.1.0]hexenes 10a and 10b (Schemes 3 and 4). Introduction of an N-atom via a modified Curtius reaction provided an easy entry to fused aminocyclopentitols (Schemes 4 and 5). Target 4 is a conformationally restricted cyclopropanefused analogue of the glycosidase inhibitors mannostatins A (2) and B (3).